BARCELONA, Spain — Adding a second immunotherapy from Bristol Myers Squibb to an existing checkpoint inhibitor and ...

Pfizer reported at #ESMO that an experimental antibody helped cancer patients with a condition known as cachexia.

A targeted immunotherapy being developed by iTeos Therapeutics and GSK, it was reported at #ESMO, delivered promising ...

A common immunotherapy approach helped stave off disease progression in patients with a form of anal cancer that is caused by ...

One of the big presentations of this year’s ESMO (at least in our view) comes tomorrow morning bright and early. David Spigel ...

A new therapy approved by the FDA is one of the first major brain tumor breakthroughs in decades, say neuro-oncologists.

Mystery H5 flu case had a close contact who was ill at same time; CDC hopes blood tests will show if there was a connection.

Patients will be able to get a 10 minute injection of the Roche drug, instead of an hours-long infusion. Novartis already has ...

A growing number of people with type 1 diabetes are becoming overweight or obese, in part because insulin can cause weight ...

For years, health insurers battled to gain market share in the lucrative privatized Medicare program. Now, the opposite is ...

Grappling with obesity and the metabolic diseases cascading from it, they are now among the plurality of Americans who have ...

Either Harris or Trump could enact changes to the health insurance market that bump HRAs off their path to growth.